Shukra Pharmaceuticals Ltd — Important, 08-10-2025: Company Update

Shukra Pharmaceuticals has confirmed its adherence to share dematerialization procedures for the quarter. Its Registrar and Transfer Agent certified that all securities received for dematerialization were properly processed, confirmed to depositories, and listed on exchanges. Physical certificates were meticulously cancelled after verification, and depository names were updated in the company's records promptly. This ensures accurate shareholder data and smooth trading operations. Notably, the company reported no shares were dematerialized during this period.